Pharmaceutical Technology's In the Lab eNewsletter, July 2023

July 05, 2023

When evaluating a drug’s risk assessment for elemental impurities, one must consider all aspects of its lifecycle.

July 05, 2023

When evaluating a drug’s risk assessment for elemental impurities, one must consider all aspects of its lifecycle.

June 26, 2023

The companies hope address the need for efficient collection, cryopreservation, quality control, and logistics capabilities of leukapheresis materials to support various aspects of the cell therapy workflow.

June 26, 2023

The Segmentation by Exogenous Perfusion system uses a cell’s location in the tumor to find differences in gene activity.

June 23, 2023

Sandbox AQ’s molecular simulation division is collaborating with companies like AstraZeneca and Sanofi to develop novel treatments for various disorders.

June 20, 2023

Researchers at the University of Waterloo have developed a liquid-liquid encapsulation system for use in sustainable encapsulation processes.

June 20, 2023

Eli Lilly & Company will pay Verve Therapeutics up to $525 million to advance a lipoprotein gene editing research program.

June 15, 2023

The bioreactor scaler tool helps scaling between development and manufacturing and to de-risk scaling activities and ensure product quality.

June 15, 2023

The integration of the binders into a routine lateral flow test will support the clinical and commercial development of rapid diagnostics for Alzheimer’s disease through nasal sampling.

June 15, 2023

Charles River’s off-the-shelf lentiviral vector packaging plasmids are intended for use with cell and gene therapies.

June 08, 2023

Sartorius and Waters will collaborate to develop integrated analytical solutions for downstream biomanufacturing.